Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 54 citing articles:

Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 323
SARS-CoV-2 viral load and shedding kinetics
Olha Puhach, Benjamin Meyer, Isabella Eckerle
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 302
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols
Paul Chen, Niklas Bobrovitz, Zahra Premji, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 147
Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study
James A. Hay, Stephen M Kissler, Joseph R. Fauver, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 90
Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 78
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
Christin Mache, Jessica Schulze, Gudrun Holland, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 69
Why Does the Severity of COVID-19 Differ With Age?
Petra Zimmermann, Nigel Curtis
The Pediatric Infectious Disease Journal (2021) Vol. 41, Iss. 2, pp. e36-e45
Open Access | Times Cited: 76
SARS-CoV-2 Incubation Period during the Omicron BA.5–Dominant Period in Japan
Tsuyoshi Ogata, Hideo Tanaka
Emerging infectious diseases (2023) Vol. 29, Iss. 3, pp. 595-598
Open Access | Times Cited: 19
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques
Christopher T Edwards, Kirti A. Karunakaran, Elijah Garcia, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012456-e1012456
Open Access
A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers
Thomas R. Moench, Lakshmi Botta, Brian T. Farrer, et al.
EBioMedicine (2025) Vol. 113, pp. 105582-105582
Closed Access
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation
Carlos King Ho Wong, Jonathan J. Lau, Ivan Chi Ho Au, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Ascertainment rate of SARS-CoV-2 infections from healthcare and community testing in the UK
Ewan Colman, Gavrila Amadea Puspitarani, Jessica Enright, et al.
Journal of Theoretical Biology (2022) Vol. 558, pp. 111333-111333
Open Access | Times Cited: 20
Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response
Paul S. Kim, Derek E. Dimcheff, Andrew Siler, et al.
Clinical Immunology (2022) Vol. 236, pp. 108959-108959
Open Access | Times Cited: 18
Symptom propagation in respiratory pathogens of public health concern: a review of the evidence
Phoebe Asplin, Rebecca Mancy, Thomas Finnie, et al.
Journal of The Royal Society Interface (2024) Vol. 21, Iss. 216
Open Access | Times Cited: 3
Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19
Jana L. Jacobs, Asma Naqvi, Faraaz Shah, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 12, pp. 2089-2094
Open Access | Times Cited: 17
Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment
Rajeev Rudraraju, Matthew J. Gartner, Jessica A. Neil, et al.
Stem Cell Reports (2023) Vol. 18, Iss. 6, pp. 1308-1324
Open Access | Times Cited: 9
Quantifying quanta: determining emission rates from clinical data
Benjamin Jones, Christopher Iddon, Max H. Sherman
Indoor Environments (2024) Vol. 1, Iss. 3, pp. 100025-100025
Open Access | Times Cited: 2
Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need
Tim Stakenborg, Joren Raymenants, Ahmed Taher, et al.
Biosensors and Bioelectronics (2022) Vol. 217, pp. 114663-114663
Open Access | Times Cited: 13
Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis
María Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial
Bruno Maranda, Sébastien M. Labbé, Magali Lurquin, et al.
The Lancet Infectious Diseases (2023)
Closed Access | Times Cited: 7
SARS-CoV-2 incidence in secondary schools; the role of national and school-initiated COVID-19 measures
Leon Jonker, Karlien Linde, Annemarijn R. de Boer, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in England
Rachel Lunt, Catherine Quinot, Freja Kirsebom, et al.
Journal of Infection (2023) Vol. 88, Iss. 1, pp. 21-29
Open Access | Times Cited: 5
Symptom propagation in respiratory pathogens of public health concern: a review of the evidence
Phoebe Asplin, Rebecca Mancy, Thomas Finnie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19
Michał Majchrzak, Łukasz Madej, Małgorzata Łysek-Gładysińska, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top